[HTML] springer.com

[HTML][HTML] Androgen receptor splice variants in the era of enzalutamide and abiraterone

M Nakazawa, ES Antonarakis, J Luo - Hormones and cancer, 2014 - Springer
The FDA approvals of enzalutamide and abiraterone have rapidly changed the clinical
landscape of prostate cancer treatment. Both drugs were designed to further suppress …
被引用次数：137 相关文章

Androgen receptor splice variants in the era of enzalutamide and abiraterone.

M Nakazawa, ES Antonarakis, J Luo - Hormones & Cancer, 2014 - europepmc.org
The FDA approvals of enzalutamide and abiraterone have rapidly changed the clinical
landscape of prostate cancer treatment. Both drugs were designed to further suppress …

Androgen Receptor Splice Variants in the Era of Enzalutamide and Abiraterone

M Nakazawa, ES Antonarakis, J Luo - Hormones and Cancer, 2014 - infona.pl
The FDA approvals of enzalutamide and abiraterone have rapidly changed the clinical
landscape of prostate cancer treatment. Both drugs were designed to further suppress …

Androgen Receptor Splice Variants in the Era of Enzalutamide and Abiraterone

M Nakazawa, ES Antonarakis… - Hormones and Cancer, 2014 - pure.johnshopkins.edu
The FDA approvals of enzalutamide and abiraterone have rapidly changed the clinical
landscape of prostate cancer treatment. Both drugs were designed to further suppress …
[HTML] nih.gov

[HTML][HTML] Androgen Receptor Splice Variants in the Era of Enzalutamide and Abiraterone

M Nakazawa, ES Antonarakis, J Luo - Hormones & Cancer, 2014 - ncbi.nlm.nih.gov
The FDA approvals of enzalutamide and abiraterone have rapidly changed the clinical
landscape of prostate cancer treatment. Both drugs were designed to further suppress …

[引用][C] Androgen Receptor Splice Variants in the Era of Enzalutamide and Abiraterone

M Nakazawa, ES Antonarakis, J Luo - Hormones and Cancer, 2014 - cir.nii.ac.jp
Androgen Receptor Splice Variants in the Era of Enzalutamide and Abiraterone | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Androgen receptor splice variants in the era of enzalutamide and abiraterone

M Nakazawa, ES Antonarakis… - Hormones & cancer, 2014 - pubmed.ncbi.nlm.nih.gov
The FDA approvals of enzalutamide and abiraterone have rapidly changed the clinical
landscape of prostate cancer treatment. Both drugs were designed to further suppress …

Androgen Receptor Splice Variants in the Era of Enzalutamide and Abiraterone

M Nakazawa, ES Antonarakis, J Luo - Hormones and Cancer, 2014 - experts.umn.edu
The FDA approvals of enzalutamide and abiraterone have rapidly changed the clinical
landscape of prostate cancer treatment. Both drugs were designed to further suppress …
[HTML] nih.gov

[HTML][HTML] Androgen Receptor Splice Variants in the Era of Enzalutamide and Abiraterone

M Nakazawa, ES Antonarakis, J Luo - Hormones & cancer, 2014 - ncbi.nlm.nih.gov
The FDA approvals of enzalutamide and abiraterone have rapidly changed the clinical
landscape of prostate cancer treatment. Both drugs were designed to further suppress …

[引用][C] Androgen receptor splice variants in the era of enzalutamide and abiraterone Horm

M Nakazawa - Cancer, 2014 - cir.nii.ac.jp
Androgen receptor splice variants in the era of enzalutamide and abiraterone Horm | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …